BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Cumulus Neuroscience Publishes Data Validating a Scalable Measurement of Neuroplasticity Using Low-Burden Dry Sensor EEG

  January 6, 2026

   · 

  4 min read
• Press Releases

  Apogee Therapeutics Announces Positive Interim Results from Phase 1b Trial of Zumilokibart (APG777), its Potentially Best-in-Class Anti-IL-13 Antibody, in Patients with Mild-to-Moderate Asthma and Highlights 2026 Anticipated Milestones and Outlook

  January 6, 2026

   · 

  10 min read
• Press Releases

  Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data

  January 6, 2026

   · 

  6 min read
• Press Releases

  Lobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition

  January 6, 2026

   · 

  11 min read
• Press Releases

  Vizient Analysis Reveals Early and Varied Drug Pricing Shifts Following Enactment of the Inflation Reduction Act

  January 6, 2026

   · 

  3 min read
• Press Releases

  Alloy Therapeutics Appoints Christian Cobaugh, Ph.D., as CEO of Alloy Genetic Medicines

  January 6, 2026

   · 

  4 min read
• Press Releases

  Biosplice Announces the Submission of its New Drug Application (NDA) to the FDA for Lorecivivint (LOR) to Treat Knee Osteoarthritis

  January 6, 2026

   · 

  7 min read
• Press Releases

  Johnson & Johnson submits application to the European Medicines Agency for TECVAYLI®▼ (teclistamab) in combination with DARZALEX® (daratumumab) subcutaneous formulation for patients with relapsed/refractory multiple myeloma

  January 6, 2026

   · 

  16 min read
• Press Releases

  Compass Pathways Establishes Strategic Collaboration with Radial to Innovate Patient Experience and Inform Potential Delivery Model of COMP360

  January 6, 2026

   · 

  7 min read
• 

  Cancer

  Gilead Keeps Dealing With $300M OncoNano Drug Delivery Cancer Pact

  OncoNano’s platform, called ON-BOARD, packages drugs in pH-sensitive micelles that ensure their specific delivery near tumors, while also preventing systemic exposure.

  January 6, 2026

   · 

  1 min read

   · 

  Tristan Manalac